
Presenter(s): Theddeus Iheanacho, MD
Target Audience: This activity is designed for Interprofessional Teams, Nurses, PAs, Pharmacists, Physicians. This activity is accredited for Interprofessional Teams, Nurses, PAs, Pharmacists, Physicians, and the Healthcare Team.
Credit Designations Available: AMA PRA Category 1 Credit™, AAPA Category 1 CME, Social Work CE Credit, Nursing Contact Hours, Pharmacy CE Credit, Interprofessional Continuing Education (IPCE) Credit
Webinar Description: This activity reviews the following key data points which are important to primary care physicians: 1) the current epidemiologic data on drug-drug interactions between opioids and other medications, 2) possible explanations for increases in drug-drug interactions, 3) physiological and pharmacokinetic basis for adverse drug interactions, and 4) strategies for reducing risk for adverse drug interactions.
Educational Objectives:
- Identify major clinically relevant drug-drug interactions between opioids and other medications
- Review possible explanations for drug-drug interactions
- Understand basic physiological and pharmacokinetic basis for adverse drug interactions
- Identify clinical strategies for reducing risk for adverse drug interactions.